Last checked at 31 Oct 2022 16:35
FOR RELEASE ON | 31 October 2022 |
IP Group plc - PDMR share purchase
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), which develops world-changing science and technology businesses across life sciences, technology and cleantech,has been notified that on 28 October 2022, Christopher Glasson, Finance Director and a PDMR, purchased a total of 74,615 ordinary shares of two pence each ("Shares") as outlined in the below table.
Name | Number of Shares acquired | Price per share (£) | Resultant beneficial interest (in Shares) |
Christopher Glasson | 74,615 | £0.59 | 137,749 |
The notification below, made in accordance with the requirements of article 19 of the UK Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Christopher Glasson | ||||
2 | Reason for the notification | |||||
a) | Position/status | Finance Director (PDMR)
| ||||
b) | Initial notification/Amendment | Initial Announcement | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | IP Group plc | ||||
b) | LEI | 213800HG22UM138WFG43 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 2p each in IP Group plc
ISIN: GB00B128J450 | ||||
b) | Nature of the transaction | Purchase of shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price | Not applicable - single transaction | ||||
e) | Date of the transaction | 28 October 2022 | ||||
f) | Place of the transaction | London Stock Exchange, Main Market | ||||
For more information, please contact:
IP Group plc | www.ipgroupplc.com |
David Baynes, Chief Financial and Operating OfficerLiz Vaughan-Adams, Communications | +44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7967 312125 |
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across life sciences, technology and cleantech (through Kiko Ventures). The Group has a strong track record of success, having been the founder investor in a number of high-profile companies including Oxford Nanopore Technologies plc, and has one of the most exciting portfolios of high-growth businesses in Europe. The Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs world-changing technologies emerging from the UK's leading universities and research institutions. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS